Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Sunitinib under preclinical development for head and neck squamous cell carcinoma

July 24, 2008

Cell Therapeutics to meet with FDA in September 2008 to discuss sBLA for Zevalin

July 23, 2008

GeneNews launches blood-based molecular colorectal cancer test, ColonSentry

July 23, 2008

Nanoparticle-mediated drug delivery suppresses metastasis in murine cancer models

July 23, 2008

Combretastatin A4 safe and effective in patients with anaplastic thyroid cancer

July 23, 2008

Alnylam grants InterfeRx license to Calando for RNAi therapeutics

July 23, 2008

Gamida-Cell enters agreement with Amgen for use of cytokines in manufacture of StemEx

July 23, 2008

Combined radiation therapy with GMX-1777 may be useful in head and neck cancer

July 23, 2008

Vascular disrupting agent ASA-404 shows benefit in mouse model of head and neck cancer

July 22, 2008

Exelixis commences phase III XL-184 trial in medullary thyroid cancer

July 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...